The pharmaceutical industry is continually seeking innovative therapies for chronic diseases. Among these advancements, FDA-Registered Peptides have emerged as a potential strategy. , Particularly Apis, Liraglutide, https://amienyhx038301.aioblogs.com/89639367/fda-approved-peptides-apis-liraglutide-tirzepatide-semaglutide